Kiltearn Partners LLP lifted its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 12.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,010,000 shares of the pharmacy operator's stock after acquiring an additional 112,900 shares during the period. Walgreens Boots Alliance accounts for 1.6% of Kiltearn Partners LLP's portfolio, making the stock its 25th largest position. Kiltearn Partners LLP owned 0.12% of Walgreens Boots Alliance worth $9,423,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds have also recently made changes to their positions in the stock. First Financial Corp IN grew its stake in Walgreens Boots Alliance by 49.2% during the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator's stock worth $25,000 after buying an additional 885 shares during the last quarter. Golden State Wealth Management LLC acquired a new position in shares of Walgreens Boots Alliance in the 4th quarter valued at $26,000. Riverview Trust Co raised its stake in shares of Walgreens Boots Alliance by 123.8% in the fourth quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator's stock worth $27,000 after purchasing an additional 1,590 shares during the last quarter. Venturi Wealth Management LLC acquired a new stake in Walgreens Boots Alliance during the 4th quarter valued at approximately $28,000. Finally, TD Private Client Wealth LLC lifted its position in Walgreens Boots Alliance by 8,670.3% during the third quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator's stock valued at $29,000 after purchasing an additional 3,208 shares during the period. 58.59% of the stock is currently owned by hedge funds and other institutional investors.
Walgreens Boots Alliance Price Performance
WBA stock traded down $0.03 during mid-day trading on Monday, reaching $11.17. The company's stock had a trading volume of 5,755,164 shares, compared to its average volume of 20,960,774. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. The company's 50 day moving average is $10.83 and its two-hundred day moving average is $9.92. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.08 and a fifty-two week high of $21.74. The stock has a market cap of $9.65 billion, a PE ratio of -1.09, a P/E/G ratio of 1.31 and a beta of 0.62.
Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last announced its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, topping analysts' consensus estimates of $0.38 by $0.13. The firm had revenue of $39.50 billion for the quarter, compared to the consensus estimate of $37.40 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The firm's revenue was up 7.6% compared to the same quarter last year. During the same quarter last year, the business posted $0.66 earnings per share. Equities research analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently commented on WBA shares. StockNews.com started coverage on shares of Walgreens Boots Alliance in a research note on Wednesday, March 26th. They set a "hold" rating on the stock. Truist Financial cut their price objective on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating for the company in a report on Friday, January 31st. Royal Bank of Canada lifted their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a "sector perform" rating in a research note on Wednesday, January 15th. Deutsche Bank Aktiengesellschaft downgraded Walgreens Boots Alliance from a "hold" rating to a "sell" rating and lowered their price target for the stock from $11.00 to $9.00 in a research report on Friday, February 28th. Finally, Wolfe Research raised Walgreens Boots Alliance to a "hold" rating in a research note on Monday, February 24th. Four analysts have rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, Walgreens Boots Alliance currently has a consensus rating of "Hold" and a consensus target price of $10.59.
Read Our Latest Analysis on Walgreens Boots Alliance
About Walgreens Boots Alliance
(
Free Report)
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Featured Articles
Before you consider Walgreens Boots Alliance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.
While Walgreens Boots Alliance currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
